Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Survival and DTH Responses

From: Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer

Patient Survival from initiation of vaccine DTH response IL-12p70 Production (pg/mL)
1 27 months No Reaction 931
2 9 months No Reaction N/A
3 7 months Positive at week 6 to KLH 2067
4 22 months Positive at weeks 6 and 14 to KLH N/A
5 15 months No Reaction 341
6 13 months No Reaction 1134
7 > 90 monthsa No Reaction N/A
8 28 months No Reaction 1714
9 50 months No Reaction 3937
  1. aPatient alive without evidence of disease; N/A: Data not available